Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
Bone. 2022 Jul;160:116416. doi: 10.1016/j.bone.2022.116416. Epub 2022 Apr 6.
Bone. 2022.
PMID: 35398293
Free article.
Clinical Trial.